Textron Inc. (BMV:TXT)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 9, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Market Capitalization	259,609	289,615	266,484	288,320	348,853	218,885
Market Cap Growth	-8.60%	8.68%	-7.57%	-17.35%	59.38%	13.59%
Enterprise Value	310,339	343,582	304,218	329,536	393,893	267,940
Last Close Price	1461.00	1654.06	1353.32	1366.99	1456.86	939.71
PE Ratio	16.88	17.38	17.11	17.17	22.81	35.80
PS Ratio	0.98	1.05	1.15	1.15	1.37	0.95
PB Ratio	1.85	1.99	2.26	2.08	2.50	1.89
P/TBV Ratio	2.69	2.91	3.36	3.06	3.65	3.00
P/FCF Ratio	24.64	22.04	18.24	13.03	13.91	24.53
P/OCF Ratio	15.02	14.13	12.45	9.93	10.65	14.40
EV/Sales Ratio	1.19	1.24	1.32	1.31	1.55	1.16
EV/EBITDA Ratio	10.58	11.19	10.77	11.20	13.77	13.28
EV/EBIT Ratio	15.05	14.95	14.10	15.19	19.12	21.53
EV/FCF Ratio	29.45	26.14	20.83	14.90	15.71	30.02
Debt / Equity Ratio	0.55	0.55	0.61	0.55	0.61	0.81
Debt / EBITDA Ratio	2.58	2.49	2.45	2.49	2.84	4.37
Debt / FCF Ratio	7.31	6.09	4.93	3.47	3.39	10.47
Asset Turnover	0.84	0.81	0.83	0.80	0.79	0.77
Inventory Turnover	2.65	2.80	2.90	2.91	2.95	2.65
Quick Ratio	0.66	0.76	0.95	1.13	1.36	1.33
Current Ratio	1.84	1.75	1.92	2.19	2.57	2.52
Return on Equity (ROE)	11.43%	11.63%	13.08%	12.38%	11.80%	5.44%
Return on Assets (ROA)	4.15%	4.22%	4.81%	4.33%	4.02%	2.58%
Return on Capital (ROIC)	6.22%	6.34%	7.16%	6.31%	5.83%	3.90%
Return on Capital Employed (ROCE)	8.70%	9.20%	10.20%	8.80%	7.90%	5.20%
Earnings Yield	5.92%	5.75%	5.84%	5.83%	4.38%	2.79%
FCF Yield	4.06%	4.54%	5.48%	7.67%	7.19%	4.08%
Dividend Yield	0.10%	0.10%	0.10%	0.11%	0.11%	0.17%
Payout Ratio	1.35%	1.46%	1.74%	1.97%	2.41%	5.83%
Buyback Yield / Dilution	5.74%	5.68%	6.14%	5.10%	1.07%	1.60%
Total Shareholder Return	5.84%	5.78%	6.24%	5.21%	1.19%	1.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.